You just read:

Data Published in Nature Communications Demonstrates CoA Therapeutics' Potential to Treat Genetically Driven Pantothenate Kinase-Associated Neurodegeneration (PKAN)

News provided by

CoA Therapeutics

Oct 23, 2018, 05:00 ET